Pulse Biosciences, Inc.’s $15 Million Rights Offering

Sonia Carcano North America Legal Chronicle
Tagged:

BakerHostetler represented Pulse Biosciences in its public rights offering. Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here